Clinical Trial Update: Topotecan for Irinotecan-Refractory SCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating the use of topotecan for irinotecan-refractory small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Lung Cancer, Refractory to Chemotherapy | Phase 2 | Status: UNKNOWN